News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,492 Results
Type
Article (88079)
Company Profile (825)
Press Release (782569)
Multimedia
Podcasts (200)
Webinars (29)
Section
Business (233314)
Career Advice (4149)
Deals (39887)
Drug Delivery (151)
Drug Development (91450)
Employer Resources (205)
FDA (18411)
Job Trends (17434)
News (398026)
Policy (39980)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3016)
Academic (2)
Accelerated approval (36)
Adcomms (36)
Allergies (154)
Alliances (56982)
ALS (183)
Alzheimer's disease (1810)
Antibody-drug conjugate (ADC) (357)
Approvals (18596)
Artificial intelligence (650)
Autoimmune disease (179)
Automation (41)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (206)
Biotechnology (490)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (680)
Cancer (5151)
Cardiovascular disease (455)
Career advice (3573)
Career pathing (42)
CAR-T (314)
CDC (60)
Celiac Disease (2)
Cell therapy (856)
Cervical cancer (38)
Clinical research (77186)
Collaboration (1879)
Company closure (5)
Compensation (1201)
Complete response letters (77)
COVID-19 (2997)
CRISPR (101)
C-suite (917)
Cystic fibrosis (155)
Data (6422)
Decentralized trials (2)
Denatured (74)
Depression (154)
Diabetes (542)
Diagnostics (7263)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (317)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (247)
Earnings (100388)
Editorial (67)
Employer branding (25)
Employer resources (174)
Events (135325)
Executive appointments (1049)
FDA (21674)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1592)
Gene editing (221)
Generative AI (69)
Gene therapy (692)
GLP-1 (1147)
Government (5461)
Grass and pollen (8)
Guidances (387)
Healthcare (20960)
HIV (66)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (302)
Immuno-oncology (66)
Indications (111)
Infectious disease (3299)
Inflammatory bowel disease (209)
Inflation Reduction Act (17)
Influenza (127)
Intellectual property (259)
Interviews (816)
IPO (17966)
IRA (61)
Job creations (5201)
Job search strategy (2867)
JPM (71)
Kidney cancer (18)
Labor market (96)
Layoffs (661)
Leadership (41)
Legal (10163)
Liver cancer (99)
Longevity (16)
Lung cancer (694)
Lymphoma (387)
Machine learning (45)
Management (66)
Manufacturing (882)
MASH (178)
Medical device (15061)
Medtech (15118)
Mergers & acquisitions (23011)
Metabolic disorders (1437)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (367)
Neuropsychiatric disorders (105)
Neuroscience (3170)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5118)
Now hiring (68)
Obesity (700)
Opinion (338)
Ovarian cancer (171)
Pain (219)
Pancreatic cancer (239)
Parkinson's disease (304)
Partnered (39)
Patents (523)
Patient recruitment (514)
Peanut (61)
People (67023)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23847)
Phase 2 (33492)
Phase 3 (25231)
Pipeline (5457)
Policy (344)
Postmarket research (3554)
Preclinical (10702)
Press Release (72)
Prostate cancer (254)
Psychedelics (58)
Radiopharmaceuticals (305)
Rare diseases (948)
Real estate (7442)
Recruiting (81)
Regulatory (29170)
Reports (68)
Research institute (2733)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (87)
Schizophrenia (162)
Series A (263)
Series B (204)
Service/supplier (30)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4336)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (124)
Vaccines (1174)
Venture capital (100)
Weight loss (482)
Women's health (96)
Worklife (22)
Date
Today (43)
Last 7 days (615)
Last 30 days (2241)
Last 365 days (32762)
2026 (3804)
2025 (33229)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (51633)
Australia (9067)
California (11796)
Canada (3388)
China (1203)
Colorado (501)
Connecticut (513)
Delaware (355)
Europe (118659)
Florida (1742)
Georgia (378)
Hawaii (4)
Idaho (68)
Illinois (981)
India (73)
Indiana (555)
Iowa (24)
Japan (448)
Kansas (134)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1476)
Massachusetts (8669)
Michigan (368)
Minnesota (675)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (86)
New Jersey (3166)
New Mexico (33)
New York (3114)
North Carolina (1639)
North Dakota (10)
Northern California (5672)
Ohio (361)
Oklahoma (23)
Oregon (55)
Pennsylvania (2352)
Puerto Rico (25)
Rhode Island (51)
South America (1665)
South Carolina (68)
South Dakota (1)
Southern California (4557)
Tennessee (180)
Texas (1860)
United States (42508)
Utah (352)
Vermont (1)
Virginia (296)
Washington D.C. (88)
Washington State (989)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
There are 871,492 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
February 16, 2026
·
1 min read
Press Releases
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update
February 16, 2026
·
5 min read
Press Releases
Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline
February 16, 2026
·
4 min read
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
February 16, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Keenova Announces New Manuscript on Plantar Fibromatosis Treatment Patterns in Peer-Reviewed Journal of Foot and Ankle Surgery
February 16, 2026
·
10 min read
Press Releases
Lilly’s Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
February 16, 2026
·
19 min read
Press Releases
Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany
February 16, 2026
·
5 min read
Press Releases
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
February 16, 2026
·
5 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - February 16, 2026
February 16, 2026
·
2 min read
Press Releases
LEX Diagnostics Receives FDA 510(k) Clearance and CLIA Waiver for LEX VELO System
February 16, 2026
·
2 min read
1 of 87,150
Next
